tirzepatide update Mission Family Medicine launches in-clinic program Big update in pediatric diabetes

Both medications can be expensive

A.AgustiniB.Khler-ForsbergO.CusinC.KatzD.SylviaL

7,21,25 A phenomenon known as inflammaging, chronic low-level inflammation that often accompanies aging, is an important driver of atherosclerosis

Semax increases BDNF and supports neuroplasticity for improved focus and memory, while Selank modulates GABA and serotonin to reduce stress without sedation

The firm acknowledged that releasing OOS compounded preparations reflects a deviation from internal quality assurance procedures and obligation to notify patients and prescribers. But the FDA found that no corrective actions were provided to address the failure to notify patients and prescribers when OOS results were identified

KEY TAKEAWAYS Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes, with demonstrated superior efficacy in glycemic control and weight loss compared to existing treatments